Skip to main content
HairCited

Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review.

Diana Gruenstein, Melissa O'Mara, Samantha Hussain Pa, Jacob Levitt, Stacy Li Pa et al.
Review Dermatology online journal 2021 3 trích dẫn
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D35130383'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Loại nghiên cứu
Cohort
Cỡ mẫu
66
Can thiệp
Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review. None
Đối chứng
Placebo
Xu hướng hiệu quả
Positive
Nguy cơ sai lệch
High

Abstract

The prevalence of telogen effluvium (TE) has increased during COVID-19. In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.

Used In Evidence Reviews

Similar Papers